Lilian Walther Jallow

My focus is on ensuring that innovation reaches the people it’s meant for. I’ve spent over 20 years in drug development for severe and rare diseases, driven by the belief that even the untreatable can be treated. My background spans research, development, manufacturing, quality control, regulatory affairs, and documentation—primarily within cell-, and gene therapy (ATMPs). With experience in both academic and industrial environments, I enjoy connecting scientific insight with practical execution. I’m motivated by the potential these therapies have to make a real difference for patients who often lack viable treatment options.